Widely used:Recently Viewed
Clear All
$123 Mln
--
0.34
--
0
-21.64 %
--
--
--
-1277285
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Seer Inc (SEER)
| 0.00 | 18.29 | 19.75 | -9.35 | -60.54 | -- | -- |
|
BSE Sensex
| 12.20 | -0.16 | 1.32 | 22.81 | 11.05 | 16.56 | 11.80 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
|
|---|---|---|---|
|
Seer Inc (SEER)
| -66.55 | -74.57 | -59.37 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
$122.86 Mln
$14.13 Mln
$0.00 Mln
$283.45 Mln
$27.10 Mln
High
$1.46 - 2.30
57,384,200
NASDAQ: SEER
Redwood City, CA
https://seer.bio
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles,... consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Read more
The total asset value of Seer Inc (SEER) stood at $ 424 Mln as on 30-Jun-24
The share price of Seer Inc (SEER) is $1.94 (NASDAQ) as of 07-Oct-2024 16:00 EDT. Seer Inc (SEER) has given a return of -60.54% in the last 3 years.
Seer Inc (SEER) has a market capitalisation of $ 123 Mln as on 04-Oct-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Seer Inc (SEER) is 0.34 times as on 04-Oct-2024, a 87% discount to its peers’ median range of 2.60 times.
Since, TTM earnings of Seer Inc (SEER) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Seer Inc (SEER) and enter the required number of quantities and click on buy to purchase the shares of Seer Inc (SEER).
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
The CEO & director of Dr. Omid C. Farokhzad M.D., Ph.D.. is Seer Inc (SEER), and CFO & Sr. VP is Dr. Omid C. Farokhzad M.D., Ph.D..
There is no promoter pledging in Seer Inc (SEER).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
324
|
|
|
185
|
|
|
126
|
|
|
123
|
| Seer Inc (SEER) | Ratios |
|---|---|
|
Return on equity(%)
|
-21.64
|
|
Operating margin(%)
|
-712.4
|
|
Net Margin(%)
|
-583.19
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Seer Inc (SEER) was $0 Mln.
$-0.06
